EUVIMEDEUVIMED entdecken
Multizentrische Studie

The Association between Aminoglycoside Exposure and Ototoxicity in Children with Cystic Fibrosis

Cansu Yilmaz Yegit, Pinar Ergenekon, Mürüvvet Yanaz, Nezafet Ozturk Akar, Fatma Toktas Yavuz, Hale Molla Kafi, Abdülhamit Çollak, Nilüfer Bal, Özge Gedik Toker, Özge Meral, Ahmet Ataş, Halide Çetin Kara und 22 weitere

Respiration · 2024

DOI: 10.1159/000541447 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Respiration, 2024. Verfasst von Cansu Yilmaz Yegit und 33 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Pulmonology, Marmara University, School of Medicine, Istanbul, Turkey. Hauptthemen laut MEDLINE: Cystic Fibrosis, Aminoglycosides, Ototoxicity, Anti-Bacterial Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Pulmonary exacerbations increase the requirement of aminoglycoside (AG) antibiotics in people with cystic fibrosis (pwCF). Several studies have shown that AGs have a cumulative effect on ototoxicity. We aimed to investigate the relationship between AG exposure and ototoxicity by using 3 different methods in patients with CF. Materials/Methods: The multicenter study included 121 pwCF aged between 5 and 18 years with a history of parenteral AG exposure. Standard pure-tone audiometry, extended high-frequency pure-tone audiometry (EHF-PTA), and distortion-product otoacoustic emissions (DPOAE) tests were performed. Mitochondrial mutation analysis for m1555G>A was performed in 61 patients.

Results

Median age was 12.85 years and 52.1% (n = 63) were male. 18.2% (n = 22) of the patients had received parenteral AGs more than 5 courses/lifetime. Ototoxicity was detected in at least one of the tests in 56.2% (n = 68) of the patients. Only 10.7% (n = 13) of the patients had reported a symptom indicating ototoxicity. 30.3% (n = 30) of the patients had ototoxicity in the low exposure group, while it was 45.5% (n = 10) in the high exposure group according to EHF-PTA (p > 0.05). Median number of parenteral amikacin courses was significantly higher in the ototoxic group (2 [1.25–5.75] vs. 2 [1–3]; p = 0.045). No m1555A>G mutation was detected in 61 patients who screened for mitochondrial mutation analysis.

Conclusion

As AG ototoxicity occurs primarily at high frequencies, EHF-PTA is important in early detecting ototoxicity. EHF-PTA and DPOAE detected ototoxicity in some patients with normal PTA results. All pwCF with a history of AG exposure should be evaluated for hearing loss since symptoms may only be noticed in the late period.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisAminoglycosidesOtotoxicityAnti-Bacterial AgentsHumansMaleFemaleChildAdolescentChild, PreschoolAudiometry, Pure-ToneOtoacoustic Emissions, SpontaneousMutation

Stichwörter der Autor:innen

AminoglycosidesCystic fibrosisOtotoxicity

Substanzen

AminoglycosidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Pediatric Pulmonology, Marmara University, School of Medicine, Istanbul, Turkey.
  • Health Science Institute, Marmara University, Istanbul, Turkey.
  • Department of Audiology, School of Medicine, Marmara University, Istanbul, Turkey.
  • Department of Pediatrics, School of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Department of Audiology, School of Medicine, Bezmialem Vakif University, Istanbul, Turkey.
  • Division of Pediatric Pulmonology, School of Medicine, Istanbul University Cerrahpasa, Istanbul, Turkey.

Zitieren

APA

Yilmaz Yegit, C., Ergenekon, P., Yanaz, M., Ozturk Akar, N., Toktas Yavuz, F., Molla Kafi, H., Çollak, A., Bal, N., Gedik Toker, Ö., Meral, Ö., Ataş, A., Çetin Kara, H., Ayhan, Y., Guliyeva, A., Yuksel Kalyoncu, M., Selçuk Balcı, M., Karabulut, Ş., Taştan, G., Uzunoglu, B., …, & Karadag, B. (2024). The Association between Aminoglycoside Exposure and Ototoxicity in Children with Cystic Fibrosis. Respiration. https://doi.org/10.1159/000541447

Vancouver

Yilmaz Yegit C, Ergenekon P, Yanaz M, Ozturk Akar N, Toktas Yavuz F, Molla Kafi H, et al. The Association between Aminoglycoside Exposure and Ototoxicity in Children with Cystic Fibrosis. Respiration. 2024. doi:10.1159/000541447

BibTeX
@article{YilmazYegit2024,
  author = {Yilmaz Yegit, Cansu and Ergenekon, Pinar and Yanaz, Mürüvvet and Ozturk Akar, Nezafet and Toktas Yavuz, Fatma and Molla Kafi, Hale and Çollak, Abdülhamit and Bal, Nilüfer and Gedik Toker, Özge and Meral, Özge and Ataş, Ahmet and Çetin Kara, Halide and Ayhan, Yetkin and Guliyeva, Aynur and Yuksel Kalyoncu, Mine and Selçuk Balcı, Merve and Karabulut, Şeyda and Taştan, Gamze and Uzunoglu, Burcu and Karasu, Nesibe and Oruc, Yesim and Acar, Melda and Yumuşakhuylu, Ali Cemal and Dogan, Remzi and Gozen Tan, Emine Deniz and Ata, Pinar and Kılınç Sakallı, Ayşe Ayzıt and Girit, Saniye and Cakir, Erkan and Gokdemir, Yasemin and Erdem Eralp, Ela and Ciprut, Ayca and Karakoc, Fazilet and Karadag, Bulent},
  title = {The Association between Aminoglycoside Exposure and Ototoxicity in Children with Cystic Fibrosis},
  journal = {Respiration},
  year = {2024},
  doi = {10.1159/000541447}
}
Kostenlos starten →